case study 2 test

Cookies on GOV.UK

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.

We also use cookies set by other sites to help us deliver content from their services.

You have accepted additional cookies. You can change your cookie settings at any time.

You have rejected additional cookies. You can change your cookie settings at any time.

• Driving and transport
• HGV, bus and coach drivers

Become a qualified heavy goods vehicle (HGV) or bus driver

Driver cpc part 2 test: case studies.

You can book the part 2 case studies test of the Driver Certificate of Professional Competence ( CPC ) as soon as you’ve got your provisional licence. You do not need to have passed the Driver CPC part 1 theory test.

If you’re requalifying as a heavy goods vehicle ( HGV ) or bus driver by taking parts 2 and 4 of the test, you cannot book your test online. You have to book by phone instead.

Driver and Vehicle Standards Agency customer services Telephone: 0300 200 1122 (choose option 01) Monday to Friday, 8am to 4pm Find out about call charges

What to take to your test

You must bring one of the following:

• a Great Britain photocard driving licence
• a Northern Ireland photocard driving licence and paper counterpart
• an EU photocard driving licence (and paper counterpart, if you have one)

If you do not have a photocard driving licence, bring your paper licence and a valid passport.

Your test will be cancelled and you’ll lose your fee if you do not bring the right documents.

Revision and practice

You can use books or software to revise for the test and take practice tests.

You can buy:

• Driver CPC : the Official DVSA Guide for Professional Goods Vehicle Drivers online if you’re learning to drive a lorry
• The Official DVSA Guide to Driving Buses and Coaches book if you’re learning to drive a bus or coach

How the test works

The test is made up of 7 case studies you work through on a computer. The case studies are short stories based on situations that you’re likely to come across in your working life.

You’ll be asked between 6 and 8 multiple-choice questions on each case study.

The test lasts for 1 hour and 15 minutes, and the pass mark is 40 out of 50.

Your test result

You’ll get a letter with the results at the test centre.

You need the test pass reference number when you book your Driver CPC part 4 practical demonstration test.

The pass letter is valid for 2 years.

You need to pass the Driver CPC part 4 practical demonstration test within 2 years, otherwise you’ll have to pass the part 2 case studies test again.

If you fail the test

You’ll get a result letter with feedback telling you why you’ve failed.

You can book another case studies test straight away, but you cannot take it for another 3 clear working days.

Cancelled tests

You can apply for a refund of out-of-pocket expenses if DVSA cancels your test at short notice.

Related content

Is this page useful.

• Yes this page is useful
• No this page is not useful

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.

To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.

CPC Case Study Test Module 2

About this app

Data safety.

What's new

App support, more by imagitech.

PCV CPC Module 2 Case Studies

Practice Module 2 Case Studies & Learning Material for the PCV (Bus) driver CPC.

90 days access for £12.50

Try for 24 hours.

If you’re not happy within 24 hours of purchase, we will give you a full refund!

Case Studies

Practice Case Studies tests – with full explanations

Money Back Guarantee

Pass first time or we will refund you course fee

DVSA Topics

Our comprehensive learning material covers every DVSA topic area. Making you well prepared for the test.

Practice case studies

60 Practice tests with full explanations will reinforce your module 2 CPC knowledge

Higher Pass Rate

Our first time pass rate is 89.4% compared to a national average of 52.2%

What to expect in the CPC Module 2 test?

The module 2 CPC test lasts 90 minutes and is made up of between 6 and 8 case studies. Prior to the test commencing, you will have 15 minutes to practice and understand how the test works. This means that you will have a maximum of 75 minutes to answer the questions on the test. The test will be carried out in a DVSA theory test centre on a desktop computer.

You need to score a minimum of 40 out of 50 to pass the test (80%) and you’ll be notified of your score when you’ve completed the test.

What You’ll Learn

All the DVSA topics are covered in-depth with our blended learning. By working your way through the study material, completing practice case studies and reviewing detailed explanations of your answers you will increase your chances of passing the PCV (bus) module 2 case studies test first time .

• Optimising Fuel Consumption
• The Ability to Ensure Passenger Comfort and Safety
• Vehicle Loading Safety Rules
• Adopting Behaviour To Enhance Your Company’s Image
• The Social Environment Of Road Transport
• The Regulations Governing Carriage of Passengers
• Economical Environment for Carriage of Passengers
• The Risks of the Road and Accidents at Work
• Preventing Criminality and Trafficking
• The Importance of Physical and Mental Ability
• The Ability To Assess Emergency Situations

Join​ Today With a Money Back Guarantee!

If you don’t pass first time, we will give you a full refund

• Study Material
• Multiple-Choice Test
• Hazard Perception
• Practice Case Studies
• Show me, Tell me
• [email protected]

140 LGV DRIVER CPC MODULE 2 PRACTICE CASE STUDIES WITH OVER 900 QUESTIONS

If you're not happy within 24 hours of purchase we'll give you a full refund

We're so confident you'll pass first time we'll refund your joining fee if you fail

What is the driver cpc, what does the part 2 case studies test consist of.

The module 2 case studies test involves a series of questions based on real-life scenarios that a student may encounter during their day to day work as the driver of a large goods vehicle.

The test is made up of seven case studies consisting of between 5-10 questions. The maximum mark for the test is 50, and a minimum of 40 is required to pass the test

EVERYTHING YOU NEED TO PASS THE LGV THEORY AND INITIAL DRIVER CPC

• Nursing Career Guide
• Premium Login
• Pass the first time, guaranteed
• Help Center

Your Progress

• 0 Incorrect
• Back to  all tests
• Font size Click here to set to default
• 0   Correct
• 0   Incorrect
• 0   Skipped

Next Generation NCLEX: Case Studies 1-2

• 2,500+ NCLEX-Like Questions (including the ones most people fail)
• 80 Realistic Practice Tests & Marathons
• 300+ SATA Questions
• 300+ NCLEX Flashcards
• Unlimited NCLEX Simulations

NCLEX-RN Fact Sheet

Nursing career guide: how to become a nurse.

Expore resources about studying for your NCLEX and becoming a nurse.

Get the NCLEX Genie App

Download our free iOS or Android app to prepare for your NCLEX exam offline or on the go.

More NCLEX-RN Practice Tests

• Basic Care and Comfort 1
• Basic Care and Comfort 2
• Basic Care & Comfort Marathon
• Pharmacological & Parenteral Therapies 1
• Pharmacological & Parenteral Therapies 2
• Pharmacological & Parenteral Therapies 3
• Pharmacological & Parenteral Therapies 4
• Drug Dosage Calculation
• Pharmacological & Parenteral Marathon
• Reduction of Risk Potential 1
• Reduction of Risk Potential 2
• Reduction of Risk Potential 3
• Reduction of Risk Potential 4
• Reduction of Risk Potential Marathon
• Physiological Adaptation 1
• Physiological Adaptation 2
• Physiological Adaptation 3
• Physiological Adaptation 4
• Physiological Adaptation Marathon
• Psychosocial Integrity Test 1
• Psychosocial Integrity Test 2
• Psychosocial Integrity Test 3
• Psychosocial Integrity Test 4
• Psychosocial Integrity Test 5
• Psychosocial Marathon
• Health Promotion and Maintenance 1
• Health Promotion and Maintenance 2
• Health Promotion and Maintenance 3
• Health Promotion and Maintenance 4
• Health Promotion and Maintenance 5
• Health Promotion Marathon
• Management of Care 1
• Management of Care 2
• Management of Care 3
• Management of Care Marathon
• Safety & Infection Control 1
• Safety & Infection Control 2
• Safety & Infection Control 3
• Safety & Infection Control Marathon
• NCLEX Exam Simulator

Breaking Down IV Fluids: The 4 Most Common Types and Their Uses

How Much Do Nurses Make?

How to Pass the NCLEX the First Time

• International
• Schools directory
• Resources Jobs Schools directory News Search

LIBF CeFS U2 Re-sit JUN 2024: CS1 - FREEBIES

Subject: Business and finance

Age range: 16+

Resource type: Assessment and revision

Last updated

• Share through email
• Share through twitter
• Share through linkedin
• Share through facebook
• Share through pinterest

PowerPoint + student worksheet to help prep case study 1 - Ben & Lucy (mortgage overpayments) Mini-mock exam - case study questions only

A PREMIUM bundle should be available soon, including: Mini mock prep PowerPoint + worksheet Mark scheme Marking grid Model answers

I also offer bundles for the complete CeFS & DipFS course - please email [email protected] for further details.

If you like the resources please leave a review - thank you.

Creative Commons "NoDerivatives"

Your rating is required to reflect your happiness.

It's good to leave some feedback.

Something went wrong, please try again later.

This resource hasn't been reviewed yet

To ensure quality for our reviews, only customers who have downloaded this resource can review it

Report this resource to let us know if it violates our terms and conditions. Our customer service team will review your report and will be in touch.

Not quite what you were looking for? Search by keyword to find the right resource:

• Share full article

Advertisement

Supported by

Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s

People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms.

By Pam Belluck

Scientists are proposing a new way of understanding the genetics of Alzheimer’s that would mean that up to a fifth of patients would be considered to have a genetically caused form of the disease.

Currently, the vast majority of Alzheimer’s cases do not have a clearly identified cause. The new designation, proposed in a study published Monday, could broaden the scope of efforts to develop treatments, including gene therapy, and affect the design of clinical trials.

It could also mean that hundreds of thousands of people in the United States alone could, if they chose, receive a diagnosis of Alzheimer’s before developing any symptoms of cognitive decline, although there currently are no treatments for people at that stage.

The new classification would make this type of Alzheimer’s one of the most common genetic disorders in the world, medical experts said.

“This reconceptualization that we’re proposing affects not a small minority of people,” said Dr. Juan Fortea, an author of the study and the director of the Sant Pau Memory Unit in Barcelona, Spain. “Sometimes we say that we don’t know the cause of Alzheimer’s disease,” but, he said, this would mean that about 15 to 20 percent of cases “can be tracked back to a cause, and the cause is in the genes.”

The idea involves a gene variant called APOE4. Scientists have long known that inheriting one copy of the variant increases the risk of developing Alzheimer’s, and that people with two copies, inherited from each parent, have vastly increased risk.

The new study , published in the journal Nature Medicine, analyzed data from over 500 people with two copies of APOE4, a significantly larger pool than in previous studies. The researchers found that almost all of those patients developed the biological pathology of Alzheimer’s, and the authors say that two copies of APOE4 should now be considered a cause of Alzheimer’s — not simply a risk factor.

The patients also developed Alzheimer’s pathology relatively young, the study found. By age 55, over 95 percent had biological markers associated with the disease. By 65, almost all had abnormal levels of a protein called amyloid that forms plaques in the brain, a hallmark of Alzheimer’s. And many started developing symptoms of cognitive decline at age 65, younger than most people without the APOE4 variant.

“The critical thing is that these individuals are often symptomatic 10 years earlier than other forms of Alzheimer’s disease,” said Dr. Reisa Sperling, a neurologist at Mass General Brigham in Boston and an author of the study.

She added, “By the time they are picked up and clinically diagnosed, because they’re often younger, they have more pathology.”

People with two copies, known as APOE4 homozygotes, make up 2 to 3 percent of the general population, but are an estimated 15 to 20 percent of people with Alzheimer’s dementia, experts said. People with one copy make up about 15 to 25 percent of the general population, and about 50 percent of Alzheimer’s dementia patients.

The most common variant is called APOE3, which seems to have a neutral effect on Alzheimer’s risk. About 75 percent of the general population has one copy of APOE3, and more than half of the general population has two copies.

Alzheimer’s experts not involved in the study said classifying the two-copy condition as genetically determined Alzheimer’s could have significant implications, including encouraging drug development beyond the field’s recent major focus on treatments that target and reduce amyloid.

Dr. Samuel Gandy, an Alzheimer’s researcher at Mount Sinai in New York, who was not involved in the study, said that patients with two copies of APOE4 faced much higher safety risks from anti-amyloid drugs.

When the Food and Drug Administration approved the anti-amyloid drug Leqembi last year, it required a black-box warning on the label saying that the medication can cause “serious and life-threatening events” such as swelling and bleeding in the brain, especially for people with two copies of APOE4. Some treatment centers decided not to offer Leqembi, an intravenous infusion, to such patients.

Dr. Gandy and other experts said that classifying these patients as having a distinct genetic form of Alzheimer’s would galvanize interest in developing drugs that are safe and effective for them and add urgency to current efforts to prevent cognitive decline in people who do not yet have symptoms.

“Rather than say we have nothing for you, let’s look for a trial,” Dr. Gandy said, adding that such patients should be included in trials at younger ages, given how early their pathology starts.

Besides trying to develop drugs, some researchers are exploring gene editing to transform APOE4 into a variant called APOE2, which appears to protect against Alzheimer’s. Another gene-therapy approach being studied involves injecting APOE2 into patients’ brains.

The new study had some limitations, including a lack of diversity that might make the findings less generalizable. Most patients in the study had European ancestry. While two copies of APOE4 also greatly increase Alzheimer’s risk in other ethnicities, the risk levels differ, said Dr. Michael Greicius, a neurologist at Stanford University School of Medicine who was not involved in the research.

“One important argument against their interpretation is that the risk of Alzheimer’s disease in APOE4 homozygotes varies substantially across different genetic ancestries,” said Dr. Greicius, who cowrote a study that found that white people with two copies of APOE4 had 13 times the risk of white people with two copies of APOE3, while Black people with two copies of APOE4 had 6.5 times the risk of Black people with two copies of APOE3.

“This has critical implications when counseling patients about their ancestry-informed genetic risk for Alzheimer’s disease,” he said, “and it also speaks to some yet-to-be-discovered genetics and biology that presumably drive this massive difference in risk.”

Under the current genetic understanding of Alzheimer’s, less than 2 percent of cases are considered genetically caused. Some of those patients inherited a mutation in one of three genes and can develop symptoms as early as their 30s or 40s. Others are people with Down syndrome, who have three copies of a chromosome containing a protein that often leads to what is called Down syndrome-associated Alzheimer’s disease .

Dr. Sperling said the genetic alterations in those cases are believed to fuel buildup of amyloid, while APOE4 is believed to interfere with clearing amyloid buildup.

Under the researchers’ proposal, having one copy of APOE4 would continue to be considered a risk factor, not enough to cause Alzheimer’s, Dr. Fortea said. It is unusual for diseases to follow that genetic pattern, called “semidominance,” with two copies of a variant causing the disease, but one copy only increasing risk, experts said.

The new recommendation will prompt questions about whether people should get tested to determine if they have the APOE4 variant.

Dr. Greicius said that until there were treatments for people with two copies of APOE4 or trials of therapies to prevent them from developing dementia, “My recommendation is if you don’t have symptoms, you should definitely not figure out your APOE status.”

He added, “It will only cause grief at this point.”

Finding ways to help these patients cannot come soon enough, Dr. Sperling said, adding, “These individuals are desperate, they’ve seen it in both of their parents often and really need therapies.”

Pam Belluck is a health and science reporter, covering a range of subjects, including reproductive health, long Covid, brain science, neurological disorders, mental health and genetics. More about Pam Belluck

The Fight Against Alzheimer’s Disease

Alzheimer’s is the most common form of dementia, but much remains unknown about this daunting disease..

How is Alzheimer’s diagnosed? What causes Alzheimer’s? We answered some common questions .

A study suggests that genetics can be a cause of Alzheimer’s , not just a risk, raising the prospect of diagnosis years before symptoms appear.

Determining whether someone has Alzheimer’s usually requires an extended diagnostic process . But new criteria could lead to a diagnosis on the basis of a simple blood test .

The F.D.A. has given full approval to the Alzheimer’s drug Leqembi. Here is what to know about i t.

Alzheimer’s can make communicating difficult. We asked experts for tips on how to talk to someone with the disease .

Blog The Education Hub

https://educationhub.blog.gov.uk/2024/04/26/when-are-year-6-sats-2024-key-dates-for-parents-and-pupils/

When are year 6 SATs 2024? Key dates for parents and pupils

Year 6 pupils in England will soon be taking the key stage 2 (KS2) national curriculum tests, which are often referred to as SATs.  

The assessments are used to measure school performance and to make sure individual pupils are being supported in the best way possible as they move into secondary school .   

When are SATs?  

This year, SATs will take place over four days from 13 May to 16 May 2024.

The timetable is as follows:

What are the tests on?   

While pupils won’t be able to see what’s on the test beforehand, t he assessments only include questions on things that children should already have been taught as part of the national curriculum.  

You can find past papers on GOV.UK .  

As usual, there won’t be a test for English writing or science. Instead, this will be reported as a teacher assessment judgement.  

This is a judgement teachers will make based on your child’s work at the end of KS2.   

Does my child need to revise for SATs?  

Children shouldn’t be made to feel any unnecessary pressure when it comes to the KS2 assessments and t eachers will make sure that all pupils in their class are prepared.  

You should follow their general advice about supporting your child’s education throughout the year and ahead of the tests.  

While it is statutory for schools to hold the assessments, headteachers make the final decision about whether a pupil participates in them.   

Some pupils – for example those with special education needs or disabilities – may be assessed under different arrangements if these are more appropriate.   

If you have concerns about your child participating in the KS2 tests, you should speak to your school in the first instance.  

What if my child finds the SATs tests too difficult?  

It’s important to remember that one of the purposes of the key stage 2 assessments is to identify each pupil's strengths and the areas where they may have fallen behind in their learning as they head into secondary school.   

The results will help their new school determine in which areas your child needs the most support.   

The tests are designed to be challenging to measure attainment, including stretching the most able children. It means some pupils will find them harder than others.    

It takes three years to create appropriate tests. During the process, they’re rigorously trialled with year 6 pupils and reviewed by education and inclusion experts to make sure they’re the right difficulty level.   

The Standards and Testing Agency (STA) is responsible for developing the tests, and Ministers don't have any influence on their content.   

When will we find out the results of SATs?  

Schools will receive test results on Tuesday 9 July 2024.  

Before the end of the summer term, your child’s school will send you a report which will include test results and teacher assessment judgements.  

This should provide you with a good sense of the standard at which your child is working in each subject.  

The school will report your child’s test results as a scaled score for each subject. This is created from the number of marks your child scores in a particular test. A scaled score:  

• below 100 means that your child may need more support to help them reach the expected standard;  
• of 100 or more means that your child is working at, or above, the expected standard for the key stage.  

If your child is working below the overall standard of the key stage, or they have special educational needs, reporting will be different, and you should speak to your child’s teacher for more information.  

You can also find more information about  results at the end of key stage 2  on GOV.UK.  

You may also be interested in:

• How we are helping to inspire primary school children about their future careers
• What is the multiplication tables check and why is it important?
• SATs leaflet for parents

Tags: KS2 , primary school , SATs , SATs 2023 , SATs results , Secondary School

Sharing and comments

Share this page, related content and links, about the education hub.

The Education Hub is a site for parents, pupils, education professionals and the media that captures all you need to know about the education system. You’ll find accessible, straightforward information on popular topics, Q&As, interviews, case studies, and more.

Please note that for media enquiries, journalists should call our central Newsdesk on 020 7783 8300. This media-only line operates from Monday to Friday, 8am to 7pm. Outside of these hours the number will divert to the duty media officer.

Members of the public should call our general enquiries line on 0370 000 2288.

Sign up and manage updates

Follow us on social media, search by date, comments and moderation policy.